Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi’s Toujeo proves non-inferior to insulin degludec in type 2 diabetes

June 26, 2018
Manufacturing and Production, Research and Development, Sales and Marketing American Diabetes Association, Sanofi, diabetes, insulin glargine, pharma, toujeo, type 2 diabetes

Sanofi took the opportunity at the American Diabetes Association (ADA) 78th Scientific Sessions in Florida to unveil new data on …

News
gwpharma

GW Pharma’s Epidiolex becomes first cannabis-based medicine available in US

June 26, 2018
Manufacturing and Production, Sales and Marketing FDA, GW Pharma, Lennox-Gastaut syndrome, UK, US, cannabidiol, cannabis

In what could prove to be a pivotal decision, UK biotech GW Pharmaceuticals has announced that its oral cannabidiol solution …

News
si_lem_new_photo_171118

Working Life: Vertex Pharma’s Simon Lem, VP, Regional General Manager of North Europe

June 25, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, Vertex pahrma, Working Life, feature, pharma

Pharmafocus caught up with Vertex Pharma’s Simon Lem to discuss his journey throughout the industry and the importance of the …

Feature
gilead-sciences

European Commission greenlights Gilead’s Biktarvy for HIV-1

June 25, 2018
Sales and Marketing Biktarvy, EU, Europe, European Commission, HIV, HIV-1, pharma

Good news for Gilead and HIV patients across the European Union today as the prominent pharma firm announced that its …

News
shutterstock_349943306

Sophiris halts cancer study after patient death

June 25, 2018
Research and Development, Sales and Marketing Cancer, Sophiris, pharma, prostate cancer

Another clinical trial has been forced to a standstill as biotech firm Sophiris revealed that a patient death had prompted …

News
lilly_entrance_web

Eli Lilly’s dulaglutide doses show blood control and weight benefits at Phase 2

June 25, 2018
Research and Development, Sales and Marketing Eli Lilly, Trulicity, diabetes, pharma

Eli Lilly has announced new data on its once-weekly, injectable glucagon-like peptide Trulicity (dulaglutide 1.5mg) and investigational 3.0 and 4.5mg …

News
sandi_peterson

J&J’s second-in-command to retire, alongside executive restructure

June 25, 2018
Medical Communications, Sales and Marketing J&J, JJ, Johnson & Johnson, pharma

Johnson & Johnson’s Group Worldwide Chairman Sandra Peterson (pictured) has announced she is to retire from her role and the …

News
roche__tree

Roche’s Tecentriq combo extends life in untreated lung cancer

June 25, 2018
Research and Development, Sales and Marketing Cancer, Roche, lung cancer, pharma, tecentriq

Roche has unveiled new data on the efficacy of Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 22, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The sun is out in the UK, it’s Friday, and the July/August issue of Pharmafocus is going to print. And, …

News

NICE backs Sanofi’s new treatment for atopic dermatitis

June 22, 2018
Medical Communications, Sales and Marketing England, NICE, Sanofi, UK, atopic dermatitis, pharma

NICE has published a positive Final Appraisal Determination FAD recommending dupilumab, in combination with topical corticosteroids, for use on the …

News
fda2outsideweb

FDA approves first continuous glucose monitoring system

June 22, 2018
Medical Communications, Sales and Marketing FDA, diabetes, pharma

The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people …

News
astrazeneca_sign_sky

AstraZeneca’s Imfinzi becomes India’s first available immunotherapy for lung cancer

June 22, 2018
Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, India, NSCLC, lung cancer, pharma

In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi (durvalumab) has secured approval in …

News
roche__tree

Roche’s Ocrevus cleared for NHS use in relapsing-remitting MS

June 22, 2018
Medical Communications, Sales and Marketing MS, NICE, UK, multiple sclerosis, pharma

Roche and multiple sclerosis (MS) patients across England and Wales are celebrating the news that healthcare watchdog NICE has recommended …

News
shutterstock_141299494

Elderly cancer cases to increase 80% by 2035, says CRUK

June 21, 2018
Medical Communications, Research and Development CRUK, Cancer, Cancer Research UK, NHS, UK, pharma

A new report from Cancer Research UK has indicated that the number of UK  citizens over the age of 75 …

News
920x920

Purdue culls 350 positions, eradicates sales force

June 21, 2018
Medical Communications, Sales and Marketing Purdue Pharma, opioid crisis, opioids, pharma

Bowing to the pressure applied by external groups for the part it has played in the ongoing opioid crisis, Purdue …

News
shutterstock_38078521

Anika’s osteoarthritis pain drug falls short at Phase 3

June 21, 2018
Research and Development Anika Therapeutics, Cingal, osteoarthritis, pharma

Anika Therapeutics has become the latest in a recent string of firms to suffer a failure in a late-stage trial, …

News

Novo’s oral semaglutide beats Victoza and Januvia in diabetes

June 21, 2018
Research and Development Januvia, MSD, Novo Nordisk, Victoza, pharma, semaglutide

Novo Nordisk has released new data for its oral semaglutide diabetes therapy from two trials, showing that the GLP-1 analogue …

News
shutterstock_138095450

Aquinnah Pharmaceuticals receives $3.4 million grant to advance ALS therapies

June 21, 2018
Research and Development, Sales and Marketing Aquinnah Pharmaceuticals, als, amyotrophic lateral sclerosis, pharma

Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders …

News
nhs_sign

NHS could save £7 billion via new diagnostic techniques

June 20, 2018
Medical Communications, Research and Development NHS, pharma

Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) has revealed that the NHS could save …

News
shutterstock_159488225

Sarepta shares surge after gene therapy leads to microdystrophin expression in DMD patients

June 20, 2018
Research and Development Duchenne Muscular Dystrophy, pharma, sarepta

This week, shares in Sarepta Therapeutics rocketed by 80% after the company released preliminary data from a Phase 1/2a trial …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026